Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
Trials
.
2020 Jun 22;21(1):556.
doi: 10.1186/s13063-020-04519-4.
Authors
Bastiaan Maes
1
,
Cedric Bosteels
2
,
Elisabeth De Leeuw
2
,
Jozefien Declercq
2
,
Karel Van Damme
2
,
Anja Delporte
2
,
Bénédicte Demeyere
2
,
Stéfanie Vermeersch
2
,
Marnik Vuylsteke
2
,
Joren Willaert
2
,
Laura Bollé
2
,
Yuri Vanbiervliet
2
,
Jana Decuypere
2
,
Frederick Libeer
2
,
Stefaan Vandecasteele
2
,
Isabelle Peene
2
,
Bart N Lambrecht
2
Affiliations
1
VIB-UGent Inflammatie-researchcentrum, Oost-Vlaanderen, Ghent, Belgium.
[email protected]
.
2
VIB-UGent Inflammatie-researchcentrum, Oost-Vlaanderen, Ghent, Belgium.
PMID:
32571394
PMCID:
PMC7306650
DOI:
10.1186/s13063-020-04519-4
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Publication types
Published Erratum